MARKET INSIGHTS
The global Glutaraldehyde (2%) ? Quaternary Ammonium (Quat) Sterilant for Endoscope High Level Disinfection Market size was valued at USD 0.85 billion in 2025. The market is projected to grow from USD 0.89 billion in 2026 to USD 1.45 billion by 2034, exhibiting a CAGR of 6.3% during the forecast period.
Glutaraldehyde (2%) combined with quaternary ammonium compounds serves as a specialized high-level disinfectant and sterilant formulation designed specifically for the reprocessing of flexible and rigid endoscopes. These solutions deliver broad-spectrum microbicidal activity against bacteria, mycobacteria, viruses, fungi, and some spores, making them essential for achieving high-level disinfection in manual or automated endoscope reprocessors where heat-sensitive instruments cannot undergo steam sterilization.
🔟 1. Advanced Sterilization Products (ASP)
Headquarters: Irving, Texas, USA
Key Offering: CIDEX line of activated glutaraldehyde solutions for manual and automated reprocessing.
ASP has been a dominant player in the endoscope reprocessing market for decades, offering reliable, FDA-cleared formulations that are compatible with a wide range of endoscope models and reprocessor systems. Their products are known for rapid activity, low residual odor, and strong material compatibility, making them a preferred choice for hospitals and ambulatory surgical centers worldwide.
Sustainability & Growth Initiatives:
- Development of low-odor, low-residue formulations to reduce staff exposure.
- Investment in automated reprocessor integration and digital monitoring tools.
- Commitment to reduce environmental impact through recyclable packaging.
🟡 2. STERIS Corporation
Headquarters: Rochester, New York, USA
Key Offering: Reusable glutaraldehyde-based chemistries compatible with manual soaking and automated endoscope reprocessors.
STERIS provides a portfolio of high-level disinfectants that combine strong antimicrobial activity with excellent material tolerance. Their solutions support both manual and automated workflows, enabling seamless integration into existing sterile processing departments and reducing downtime.
Sustainability & Growth Initiatives:
- Fast-acting formulations with reduced contact times.
- Enhanced compatibility with newer endoscope designs.
- Digital tracking of solution concentration and usage.
🟠 3. McKesson Corporation
Headquarters: Irving, Texas, USA
Key Offering: Distribution of glutaraldehyde-based disinfectants and reprocessing solutions.
McKesson serves as a key distributor, ensuring that hospitals and clinics have timely access to validated high-level disinfectants. Their extensive logistics network supports rapid replenishment and training for reprocessing personnel.
Sustainability & Growth Initiatives:
- Streamlined supply chain to reduce waste.
- Partnerships with manufacturers for on-site validation.
- Educational programs on safe handling and disposal.
🟢 4. Micro-Scientific, LLC
Headquarters: Chicago, Illinois, USA
Key Offering: Surfactant-free glutaraldehyde solutions for sensitive endoscope materials.
Micro-Scientific focuses on niche formulations that preserve delicate polymers and adhesives in endoscopes, reducing the risk of corrosion or degradation. Their products are popular among specialty clinics that require gentle yet effective disinfection.
Sustainability & Growth Initiatives:
- Formulation of surfactant-free solutions to minimize residue.
- Enhanced material compatibility studies.
- Eco-friendly packaging options.
🟣 5. Healthpoint Ltd.
Headquarters: New York, New York, USA
Key Offering: Ready-to-use glutaraldehyde solutions with built-in test strips.
Healthpoint offers user-friendly products that simplify the reprocessing workflow. Their test strips enable real-time monitoring of solution concentration, ensuring consistent efficacy and compliance.
Sustainability & Growth Initiatives:
- Integration of test strip technology for real-time validation.
- Reduced packaging waste through refillable containers.
- Training modules for staff safety.
🔵 6. MediVators, Inc.
Headquarters: Charlotte, North Carolina, USA
Key Offering: High-level disinfectants with rapid action and low odor.
MediVators focuses on fast-acting solutions that reduce processing time without compromising antimicrobial efficacy, making them ideal for high-volume endoscopy suites.
Sustainability & Growth Initiatives:
- Formulation of low-odor, low-residue solutions.
- Partnerships with automated reprocessor manufacturers.
- Continuous improvement of material compatibility.
🟤 7. Dongindang Pharmaceutical Co., Ltd.
Headquarters: Seoul, South Korea
Key Offering: Cost-effective glutaraldehyde solutions for emerging markets.
Dongindang provides affordable, high-quality disinfectants that meet international standards, catering to hospitals in Asia-Pacific regions where budget constraints are significant.
Sustainability & Growth Initiatives:
- Local manufacturing to reduce carbon footprint.
- Compliance with global safety regulations.
- Training programs for safe handling.
🟪 8. Shandong Lircon Medical Technology Co., Ltd.
Headquarters: Shandong, China
Key Offering: Advanced glutaraldehyde formulations for high-level disinfection.
Shandong Lircon delivers high-performance disinfectants that are compatible with the latest endoscope technologies, supporting hospitals across China and neighboring countries.
Sustainability & Growth Initiatives:
- Research into eco-friendly packaging.
- Partnerships with local hospitals for validation.
- Continuous product innovation.
🟧 9. SIRMAXO CHEMICALS PVT. LTD.
Headquarters: Bangalore, India
Key Offering: Affordable glutaraldehyde solutions for resource-constrained settings.
SIRMAXO focuses on providing reliable disinfectants that meet stringent safety standards while remaining cost-effective for public hospitals and diagnostic centers in India.
Sustainability & Growth Initiatives:
- Low-odor formulations to protect staff.
- Training on safe disposal practices.
- Eco-friendly production processes.
🟧 10. BASF SE
Headquarters: Ludwigshafen, Germany
Key Offering: Advanced chemical solutions for high-level disinfection.
BASF leverages its global R&D capabilities to develop innovative disinfectants that meet evolving regulatory requirements and enhance material compatibility across endoscope models.
Sustainability & Growth Initiatives:
- Investment in green chemistry.
- Partnerships with medical device manufacturers.
- Digital solutions for solution monitoring.
Download FREE Sample Report: Glutaraldehyde (2%) ? Quaternary Ammonium (Quat) Sterilant for Endoscope High Level Disinfection Market – View in Detailed Research Report
Get Full Report Here: Glutaraldehyde (2%) ? Quaternary Ammonium (Quat) Sterilant for Endoscope High Level Disinfection Market – View in Detailed Research Report
Outlook
The market is expected to continue its upward trajectory, growing from USD 0.85 billion in 2025 to USD 1.45 billion by 2034, driven by the rising volume of endoscopic procedures, heightened focus on preventing healthcare-associated infections, and stringent regulatory compliance. The CAGR of 6.3% reflects steady demand across North America, Europe, Asia-Pacific, and emerging markets.
Future Trends
Key trends shaping the market include the shift toward safer, low-odor formulations that mitigate occupational exposure, the integration of disinfectants with automated endoscope reprocessors to streamline workflows, and the development of hybrid chemistries that combine glutaraldehyde with quaternary ammonium compounds for enhanced cleaning performance. Additionally, digital tracking and real-time monitoring of disinfectant concentration are becoming standard practice, ensuring consistent high-level disinfection and compliance with evolving infection control guidelines.
- Top 10 Companies in the Top Liquid Carton Market (2026): Market Leaders Powering Global Packaging - June 27, 2026
- Top 10 Companies in the Global Wood Flame Retardant Market (2026): Market Leaders Powering Global Wood Flame Retardant Market - June 27, 2026
- Top 10 Companies in the UV Ink for Screen Printing Market (2026): Market Leaders Powering Global Printing - June 27, 2026